Phase 3 trial of gilteritinib plus azacitidine vs azacitidine for newly diagnosed FLT3mut+ AML ineligible for intensive chemotherapy

ES Wang, P Montesinos, MD Minden… - Blood, The Journal …, 2022 - ashpublications.org
Abstract Treatment results for patients with newly diagnosed FMS-like tyrosine kinase 3
(FLT3)-mutated (FLT3 mut+) acute myeloid leukemia (AML) ineligible for intensive …

FLT3 inhibition: a moving and evolving target in acute myeloid leukaemia

AYH Leung, CH Man, YL Kwong - Leukemia, 2013 - nature.com
Internal tandem duplication (ITD) of the fms-like tyrosine kinase 3 (FLT3) gene is a gain-of-
function mutation common in acute myeloid leukaemia (AML). It is associated with inferior …

Trisomy 8 as the sole chromosomal aberration in acute myeloid leukemia and myelodysplastic syndromes

K Paulsson, B Johansson - Pathologie Biologie, 2007 - Elsevier
Trisomy 8 as the sole abnormality is the most common karyotypic finding in acute myeloid
leukemia (AML) and myelodysplastic syndromes (MDS), occurring in approximately 5% and …

Prognostic relevance of FLT3-TKD mutations in AML: the combination matters—an analysis of 3082 patients

U Bacher, C Haferlach, W Kern… - Blood, The Journal …, 2008 - ashpublications.org
We characterized the mutational status of the FLT3 tyrosine kinase domain (FLT3-TLD) in
3082 patients with newly diagnosed AML. FLT3-TKD mutations were detected in 147 of …

Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations for acute myeloid leukemia: a meta-analysis

M Yanada, K Matsuo, T Suzuki, H Kiyoi, T Naoe - Leukemia, 2005 - nature.com
Two distinct forms of fms-like tyrosine kinase (FLT3) gene aberrations, internal tandem
duplication (ITD) and tyrosine kinase domain (TKD) mutations, have been recognized in a …

FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal …

SP Whitman, AS Ruppert… - Blood, The Journal …, 2008 - ashpublications.org
The prognostic relevance of FLT3 D835/I836 mutations (FLT3-TKD) in cytogenetically
normal acute myeloid leukemia (CN-AML) remains to be established. After excluding …

A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trial

C Röllig, C Thiede, M Gramatzki… - Blood, The Journal …, 2010 - ashpublications.org
We present an analysis of prognostic factors derived from a trial in patients with acute
myeloid leukemia older than 60 years. The AML96 trial included 909 patients with a median …

[HTML][HTML] Genetics of acute myeloid leukemia in the elderly: mutation spectrum and clinical impact in intensively treated patients aged 75 years or older

VV Prassek, M Rothenberg-Thurley, MC Sauerland… - …, 2018 - ncbi.nlm.nih.gov
A cute myeloid leukemia is a disease of the elderly (median age at diagnosis, 65–70 years).
The prognosis of older acute myeloid leukemia patients is generally poor. While genetic …

Prognostic value of FLT3 mutations among different cytogenetic subgroups in acute myeloid leukemia

FPS Santos, D Jones, W Qiao, JE Cortes, F Ravandi… - Cancer, 2011 - Wiley Online Library
BACKGROUND: The impact of FMS‐like tyrosine kinase 3 (FLT3) mutations and mutation
burden among cytogenetic subgroups of patients with acute myeloid leukemia (AML) other …

Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group

C Callens, S Chevret, JM Cayuela, B Cassinat… - Leukemia, 2005 - nature.com
Internal tandem duplications (ITDs) of the FLT3 gene have been observed in about 35% of
APL cases. If FLT3-ITD is associated with a worse outcome in patients with acute myeloid …